SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/27/2019
Entire Document
 

Schedule 4.1(c)

 

Capitalization of Subsidiaries

 

Subsidiary Authorized Capital Stock Percentage of Shares Owned Directly or Indirectly by Pernix Therapeutics Holdings, Inc. Direct Parent
Pernix Manufacturing, LLC N/A 100% Pernix Holdco 3, LLC
Pernix Holdco 3, LLC N/A 100% Pernix Therapeutics Holdings, Inc.
Pernix Holdco 2, LLC N/A 100% Cypress Pharmaceuticals, Inc.
Pernix Holdco 1, LLC N/A 100% Pernix Therapeutics, LLC
Pernix Ireland Limited (f/k/a Worrigan Limited) 100,000 ordinary shares authorized, par value 1.00 euro. 100 shares outstanding owned by Pernix Therapeutics Holdings, Inc. 100% Pernix Therapeutics Holdings, Inc.
Pernix Ireland Pain Limited (f/k/a Ferrimill Limited) 100,000 ordinary shares authorized, par value 1.00 euro. 100 shares outstanding owned by   Pernix Therapeutics Holdings, Inc. 100% Pernix Therapeutics Holdings, Inc.
Pernix Therapeutics, LLC N/A 100% Pernix Holdco 3, LLC
PERNIX SLEEP, INC. 1,000 shares of common stock authorized 100% Pernix Holdco 3, LLC
Cypress Pharmaceuticals, Inc. 100,000 shares of common stock authorized, 1,000 shares outstanding owned by Pernix Holdco 3, LLC 100% Pernix Holdco 3, LLC
Hawthorn Pharmaceuticals, Inc. 1,000 shares of common stock authorized, 1,000 shares owned by Pernix Holdco 2, LLC 100% Pernix Holdco 2, LLC
Macoven Pharmaceuticals, L.L.C. N/A 100% Pernix Holdco 1, LLC
GAINE, INC. 1,000,000 shares of common stock authorized 100% Pernix Holdco 1, LLC
Respicopea Inc. 10,000,000 shares of common stock authorized 100% Pernix Holdco 1, LLC

Schedule 4.1(c)